Evidence map›Paper›PMID 36211467›Full record

ReviewFrontiers in cell and developmental biology2022

B cell-T cell interplay in immune regulation: A focus on follicular regulatory T and regulatory B cell functions.

Diaoyi Tan, Wei Yin, Fei Guan, Wanjiang Zeng, Pamela Lee, Fabio Candotti, Louisa K James, Niels Olsen Saraiva Camara, S M Mansour Haeryfar, Yan Chen and 6 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. VISTAFrontiers in immunology · 2025
    Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 8 countries.

Diaoyi TanDepartment of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science Technology, Wuhan, China.
Wei YinWuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Fei GuanDepartment of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science Technology, Wuhan, China.
Wanjiang ZengDepartment of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Pamela LeeDepartment of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Fabio CandottiDivision of Immunology and Allergy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Louisa K JamesCentre for Immunobiology, Bizard Institute, Queen Mary University of London, London, United Kingdom.
Niels Olsen Saraiva CamaraDepartment of Immunology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, SP, Brazil.
S M Mansour HaeryfarDepartment of Microbiology and Immunology, Western University, London, ON, Canada.
Yan ChenThe Second Department of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Kamel BenlaghaUniversité de Paris, Institut de Recherche Saint-Louis, EMiLy, Paris, France.
Lewis Zhichang ShiDepartment of Radiation Oncology University of Alabama at Birmingham School of Medicine (UAB-SOM) UAB Comprehensive Cancer Center, Jinzhou, China.
Jiahui LeiDepartment of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science Technology, Wuhan, China.
Quan GongClinical Molecular Immunology Center, School of Medicine, Yangtze University, Jinzhou, China.
Zheng LiuDepartment of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chaohong LiuDepartment of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science Technology, Wuhan, China.
Huazhong University of Science and Technology · CNQueen Mary University of London · GBUniversidade de São Paulo · BRUniversité Paris Cité · FRUniversity of Alabama at Birmingham · USUniversity of Hong Kong · HKUniversity of Lausanne · CHWestern University · CAWuhan Children's Hospital · CNYangtze University · CNZunyi Medical University · CN

Funding

Overcoming Tumor-Intrinsic Therapeutic Resistance to ImmunotherapiesR21CA259721 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SHI, LEWIS ZHICHANG · 2022 to 2023
$378k
Targeting metabolic checkpoints in the tumor microenvironment to boost efficacy of anti-CTLA-4R21CA230475 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SHI, LEWIS ZHICHANG · 2019 to 2020
$355k
NCI NIH HHS R21 CA230475NCI NIH HHS R21 CA259721
6 · The paper itself

Abstract

B cells are the core components of humoral immunity. A mature B cell can serve in multiple capacities, including antibody production, antigen presentation, and regulatory functions. Forkhead box P3 (FoxP3)-expressing regulatory T cells (Tregs) are key players in sustaining immune tolerance and keeping inflammation in check. Mounting evidence suggests complex communications between B cells and Tregs. In this review, we summarize the yin-yang regulatory relationships between B cells and Tregs mainly from the perspectives of T follicular regulatory (Tfr) cells and regulatory B cells (Bregs). We discuss the regulatory effects of Tfr cells on B cell proliferation and the germinal center response. Additionally, we review the indispensable role of B cells in ensuring homeostatic Treg survival and describe the function of Bregs in promoting Treg responses. Finally, we introduce a new subset of Tregs, termed Treg-of-B cells, which are induced by B cells, lake the expression of FoxP3 but still own immunomodulatory effects. In this article, we also enumerate a sequence of research from clinical patients and experimental models to clarify the role of Tfr cells in germinal centers and the role of convention B cells and Bregs to Tregs in the context of different diseases. This review offers an updated overview of immunoregulatory networks and unveils potential targets for therapeutic interventions against cancer, autoimmune diseases and allograft rejection.

Indexed as

B cellsgerminal centerhumoral responsesregulatory B cells (bregs)regulatory T cellsT follicular regulatory cellstreg-of-B cells

Identifiers

PMID36211467
PMCPMC9537379
OpenAlexW4296831508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.